Citi Flags Agilent Technologies, Trims Icon Target
Citi issued a life sciences sector note that elevates Agilent Technologies while reducing Icon PLC’s target, signalin...
Regular budget reviews help you stay aligned with goals and changing circumstances. Learn the optimal review cadence and what to check during each session.
14,905 articlesCiti issued a life sciences sector note that elevates Agilent Technologies while reducing Icon PLC’s target, signalin...
As inheritance-driven real estate transfers rise, lenders face a new set of conversations with borrowers. A fresh sur...
As Vivid Seats reports Q4 2025 results, investors face a pivotal moment. This article breaks down revenue drivers, ma...
Two durable energy bets stand out in 2026, blending a royalty based producer with a diversified energy fund to weathe...
As market volatility persists in March 2026, traders are eyeing best stocks under $10 for potential gains. The group ...
The market recently pulled back from UPS gains, but a dip can signal opportunity for patient investors. This guide la...
ULTY’s weekly payouts look generous on the surface, yet a deeper dive shows a growing dependence on returning princip...
Rivian has faced a steep stock decline since its 2021 IPO. This piece explores whether could this catalyst that sits ...
Index funds and ETFs promise broad market exposure, but hidden concentration can undermine diversification. This guid...
AI momentum is reshaping markets. This guide dives into what best artificial intelligence stocks to buy now, how to s...
As Enhabit prepares to report its first-quarter results, investors need a clear playbook. This guide breaks down what...
HSBC is reportedly weighing a plan to cut about 20,000 jobs, roughly 10% of its global staff, in a bid to curb inflat...